{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:50:31Z","timestamp":1772689831852,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T00:00:00Z","timestamp":1389052800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00431-013-2258-2","type":"journal-article","created":{"date-parts":[[2014,1,6]],"date-time":"2014-01-06T04:40:22Z","timestamp":1388983222000},"page":"805-813","source":"Crossref","is-referenced-by-count":17,"title":["Enzyme replacement therapy in juvenile glycogenosis type II: a longitudinal study"],"prefix":"10.1007","volume":"173","author":[{"given":"Laura","family":"Deroma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Ciana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Cisilino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Dardis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Bembi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,7]]},"reference":[{"key":"2258_CR1","first-page":"132","volume":"3","author":"A Amalfitano","year":"2001","unstructured":"Amalfitano A, Bengur AR, Morse RP, Majure JM, Case LE, Veerling DL, Mackey J, Kishnani PS, Smith W, McVie-Wylie A, Sullivan JA, Hoganson GE, Phillips JA 3rd, Schaefer GB, Charrow J, Ware RE, Bossen EH, Chen YT (2001) Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial. Genet Med 3:132\u2013138","journal-title":"Genet Med"},{"key":"2258_CR2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1399-0004.2007.00785.x","volume":"71","author":"C Angelini","year":"2007","unstructured":"Angelini C, Nascimbeni AC (2007) Late-onset GSDII with novel GAA gene mutation. Clin Genet 71:374\u2013375","journal-title":"Clin Genet"},{"key":"2258_CR3","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s00415-011-6293-5","volume":"259","author":"C Angelini","year":"2012","unstructured":"Angelini C, Semplicini C, Ravaglia S, Bembi B, Servidei S, Pegoraro E, Moggio M, Filosto M, Sette E, Crescimanno G, Tonin P, Parini R, Morandi L, Marrosu G, Greco G, Musumeci O, Di Iorio G, Siciliano G, Donati MA, Carubbi F, Ermani M, Mongini T, Toscano A (2012) Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years. J Neurol 259:952\u2013958","journal-title":"J Neurol"},{"key":"2258_CR4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","volume":"166","author":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories","year":"2002","unstructured":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111\u2013117","journal-title":"Am J Respir Crit Care Med"},{"key":"2258_CR5","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1212\/WNL.52.4.851","volume":"52","author":"MG Ausems","year":"1999","unstructured":"Ausems MG, Lochman P, van Diggelen OP, Ploos van Amstel HK, Reuser AJJ, Wokke JH (1999) A diagnostic protocol for adult-onset glycogen storage disease type II. Neurology 52:851\u2013853","journal-title":"Neurology"},{"key":"2258_CR6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ajmg.c.31319","volume":"160C","author":"DS Bali","year":"2012","unstructured":"Bali DS, Goldstein JL, Banugaria S, Dai J, Mackey J, Rehder C, Kishnani PS (2012) Predicting cross-reactive immunological material (CRIM) status in Pompe disease using GAA mutations: lessons learned from 10 years of clinical laboratory testing experience. Am J Med Genet C: Semin Med Genet 160C:40\u201349","journal-title":"Am J Med Genet C: Semin Med Genet"},{"key":"2258_CR7","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1212\/WNL.0b013e31818da91e","volume":"71","author":"B Bembi","year":"2008","unstructured":"Bembi B, Cerini E, Danesino C, Donati MA, Gasperini S, Morandi L, Musumeci O, Parenti G, Ravaglia S, Seidita F, Toscano A, Vianello A (2008) Diagnosis of glycogenosis type II. Neurology 71:S4\u2013S11","journal-title":"Neurology"},{"key":"2258_CR8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10545-010-9201-8","volume":"33","author":"B Bembi","year":"2010","unstructured":"Bembi B, Pisa FE, Confalonieri M, Ciana G, Fiumara A, Parini R, Rigoldi M, Moglia A, Costa A, Carlucci A, Danesino C, Pittis MG, Dardis A, Ravaglia S (2010) Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II. J Inherit Metab Dis 33:727\u2013735","journal-title":"J Inherit Metab Dis"},{"key":"2258_CR9","first-page":"377","volume":"14","author":"GAV Borg","year":"1982","unstructured":"Borg GAV (1982) Psycho-physical bases of perceived exertion. Med Sci Sports Exerc 14:377\u2013381","journal-title":"Med Sci Sports Exerc"},{"key":"2258_CR10","first-page":"1533","volume-title":"Myology: basic and clinical","author":"AG Engel","year":"1994","unstructured":"Engel AG, Hirschhorn R (1994) Acid maltase deficiency. In: Engel A, Franzini-Armstrong C (eds) Myology: basic and clinical. McGraw-Hill, New York, pp 1533\u20131553"},{"key":"2258_CR11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jpeds.2006.12.052","volume":"150","author":"R Geiger","year":"2007","unstructured":"Geiger R, Strasak A, Treml B, Gasser K, Kleinsasser A, Fisher V, Geiger H, Loeckinger A, Stein JI (2007) Six-minute walk test in children and adolescents. J Pediatr 150:395\u2013399","journal-title":"J Pediatr"},{"key":"2258_CR12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1212\/01.wnl.0000198776.53007.2c","volume":"66","author":"ML Hagemans","year":"2006","unstructured":"Hagemans ML, Hop WJ, Van Doorn PA, Reuser AJ, Van der Ploeg AT (2006) Course of disability and respiratory function in untreated late-onset Pompe disease. Neurology 66:581\u2013583","journal-title":"Neurology"},{"key":"2258_CR13","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1212\/01.WNL.0000165979.46537.56","volume":"64","author":"ML Hagemans","year":"2005","unstructured":"Hagemans ML, Winkel LP, Hop WC, Reuser AJ, Van Doorn PA, Van der Ploeg AT (2005) Disease severity in children and adults with Pompe disease related to age and disease duration. Neurology 64:2139\u20132141","journal-title":"Neurology"},{"key":"2258_CR14","first-page":"3389","volume-title":"The metabolic and molecular bases of inherited disease","author":"R Hirschhorn","year":"2001","unstructured":"Hirschhorn R, Reuser AJJ (2001) Glycogen storage disease type II: acid \u03b1-glucosidase (acid maltase) deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 3389\u20133420","edition":"8"},{"key":"2258_CR15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","volume":"68","author":"PS Kishnani","year":"2007","unstructured":"Kishnani PS, Corzo D, Nicolino M, Byrne B, Mandel H, Hwu WL, Leslie N, Levine J, Spencer C, McDonald M, Li J, Dumontier J, Halberthal M, Chien YH, Hopkin R, Vijayaraghavan S, Gruskin D, Bartholomew D, van der Ploeg A, Clancy JP, Parini R, Morin G, Beck M, De la Gastine GS, Jokic M, Thurberg B, Richards S, Bali D, Davison M, Worden MA, Chen YT, Wraith JE (2007) Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology 68:99\u2013109","journal-title":"Neurology"},{"key":"2258_CR16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","volume":"148","author":"PS Kishnani","year":"2006","unstructured":"Kishnani PS, Hwu WL, Mandel H, Nicolino M, Yong F, Corzo D (2006) A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr 148:671\u2013676","journal-title":"J Pediatr"},{"key":"2258_CR17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nmd.2004.10.009","volume":"15","author":"L Klinge","year":"2005","unstructured":"Klinge L, Straub V, Neudorf U, Schaper J, Bosbach T, Gorlinger K, Wallot M, Richards S, Voit T (2005) Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial. Neuromuscul Disord 15:24\u201331","journal-title":"Neuromuscul Disord"},{"key":"2258_CR18","first-page":"1","volume":"314","author":"RJ Kuczmarski","year":"2000","unstructured":"Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL (2000) CDC growth charts: United States. Adv Data 314:1\u201327","journal-title":"Adv Data"},{"key":"2258_CR19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/archneur.1984.04050130053022","volume":"41","author":"T Matsuishi","year":"1984","unstructured":"Matsuishi T, Yoshino M, Terasawa K, Nonaka I (1984) Childhood acid maltase deficiency: a clinical, biochemical, and morphologic study of three patients. Arch Neurol 41:47\u201352","journal-title":"Arch Neurol"},{"key":"2258_CR20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J (2005) Standardisation of spirometry. Eur Respir J 26:319\u2013338","journal-title":"Eur Respir J"},{"key":"2258_CR21","first-page":"304","volume":"76","author":"JC Pompe","year":"1932","unstructured":"Pompe JC (1932) Over idiopathische hypertrophie van het hart. Ned Tijdschr Geneeskd 76:304\u2013312","journal-title":"Ned Tijdschr Geneeskd"},{"key":"2258_CR22","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1002\/mus.880181414","volume":"3","author":"AJ Reuser","year":"1995","unstructured":"Reuser AJ, Kroos MA, Hermans MM, Bijvoet AG, Verbeet MP, Van Diggelen OP, Kleijer WJ, Van der Ploeg AT (1995) Glycogenosis type II (acid maltase deficiency). Muscle Nerve 3:S61\u2013S69","journal-title":"Muscle Nerve"},{"key":"2258_CR23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/mus.20665","volume":"35","author":"AE Slonim","year":"2007","unstructured":"Slonim AE, Bulone L, Goldberg T, Minikes J, Slonim E, Galanko J, Martiniuk F (2007) Modification of the natural history of adult onset acid maltase deficiency by nutrition and exercise therapy. Muscle Nerve 35:70\u201377","journal-title":"Muscle Nerve"},{"key":"2258_CR24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1067\/mpd.2000.107112","volume":"137","author":"AE Slonim","year":"2000","unstructured":"Slonim AE, Bulone L, Ritz S, Goldberg T, Chen A, Martiniuk F (2000) Identification of two subtypes of infantile acid maltase deficiency. J Pediatr 137:283\u2013285","journal-title":"J Pediatr"},{"key":"2258_CR25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00415-009-5275-3","volume":"257","author":"S Strothotte","year":"2010","unstructured":"Strothotte S, Strigl-Pill N, Grunert B, Kornblum C, Eger K, Wessig C, Deschauer M, Breunig F, Glocker FX, Vielhaber S, Brejova A, Hilz M, Reiners K, Muller-Felber W, Mengel E, Spranger M, Schoser B (2010) Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial. J Neurol 257:91\u201397","journal-title":"J Neurol"},{"key":"2258_CR26","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/labinvest.3700484","volume":"86","author":"BL Thurberg","year":"2006","unstructured":"Thurberg BL, Lynch Maloney C, Vaccaro C, Afonso K, Tsai AC, Bossen E, Kishnani PS, O\u2019Callaghan M (2006) Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease. Lab Investig 86:1208\u20131220","journal-title":"Lab Investig"},{"key":"2258_CR27","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00415-012-6636-x","volume":"260","author":"A Toscano","year":"2013","unstructured":"Toscano A, Schoser B (2013) Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review. J Neurol 260:951\u2013959","journal-title":"J Neurol"},{"key":"2258_CR28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.nmd.2010.07.277","volume":"20","author":"CI Capelle Van","year":"2010","unstructured":"Van Capelle CI, van der Beek NA, Hagemans ML, Arts WF, Hop WC, Lee P, Jaeken J, Frohn-Mulder IM, Merkus PJ, Corzo D, Puga AC, Reuser AJ, van der Ploeg AT (2010) Effect of enzyme therapy in juvenile patients with Pompe disease: a three-year open-label study. Neuromuscul Disord 20:775\u2013782","journal-title":"Neuromuscul Disord"},{"key":"2258_CR29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1542\/peds.112.2.332","volume":"112","author":"HMP Hout Van den","year":"2003","unstructured":"Van den Hout HMP, Hop W, van Diggelen OP, Smeitink JA, Smit GP, Poll-The BT, Bakker HD, Loonen MC, De Klerk JB, Reuser AJ, van der Ploeg AT (2003) The natural course of infantile Pompe\u2019s disease: 20 original cases compared with 133 cases from the literature. Pediatrics 112:332\u2013340","journal-title":"Pediatrics"},{"key":"2258_CR30","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","volume":"113","author":"JM Hout Van den","year":"2004","unstructured":"Van den Hout JM, Kamphoven JH, Winkel LP, Arts WF, De KlerK JB, Loonen MC, Vulto AG, Cromme-Dijkhuis A, Weisglas-Kuperus N, Hop W, van Hirtum H, van Diggelen OP, Boer M, Kroos MA, van Doorn PA, van der Voort E, Sibbles B, van Corven EJ, Brakenhoff JP, van Hove J, Smeitink JA, de Jong G, Reuser AJ, van der Ploeg AT (2004) Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. Pediatrics 113:e448\u2013e457","journal-title":"Pediatrics"},{"key":"2258_CR31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(00)02533-2","volume":"356","author":"JM Hout Van den","year":"2000","unstructured":"Van den Hout JM, Reuser AJ, Vulto AG, Loonen MC, Cromme-Dijkhuis A, Van der Ploeg AT (2000) Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. Lancet 356:397\u2013398","journal-title":"Lancet"},{"key":"2258_CR32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.nmd.2008.11.007","volume":"19","author":"NA Beek Van der","year":"2009","unstructured":"Van der Beek NA, Hagemans ML, Reuser AJ, Hop WC, Van der Ploeg AT, Van Doorn PA, Wokke JH (2009) Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease. Neuromuscul Disord 19:113\u2013117","journal-title":"Neuromuscul Disord"},{"key":"2258_CR33","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymgme.2012.09.015","volume":"107","author":"AT Ploeg Van der","year":"2012","unstructured":"Van der Ploeg AT, Barohn R, Carlson L, Charrow J, Clemens PR, Hopkin RJ, Kishnani PS, Laforet P, Morgan C, Nations S, Pestronk A, Plotkin H, Rosenbloom BE, Sims KB, Tsao E (2012) Open-label extension study following the late-onset treatment study (LOTS) of alglucosidase alfa. Mol Genet Metab 107:456\u2013461","journal-title":"Mol Genet Metab"},{"key":"2258_CR34","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","volume":"362","author":"AT Ploeg Van der","year":"2010","unstructured":"Van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ, Herson S, Kishnani PS, Laforet P, Lake SL, Lange DJ, Leshner RT, Mayhew JE, Morgan C, Nozaki K, Park DJ, Pestronk A, Rosenbloom B, Skrinar A, van Capelle CI, van der Beek NA, Wasserstein M, Zivkovic SA (2010) A randomized study of alglucosidase alfa in late-onset Pompe\u2019s disease. N Engl J Med 362:1396\u20131406","journal-title":"N Engl J Med"},{"key":"2258_CR35","first-page":"1771","volume-title":"Disorders of voluntary muscle","author":"J Walton","year":"1994","unstructured":"Walton J, Rowland L (1994) Clinical examination, differential diagnosis and classification. In: Walton J, Karpati G, Hilton-Jones D (eds) Disorders of voluntary muscle, 6th edn. Churchill Livingstone, New York, p 1771","edition":"6"},{"key":"2258_CR36","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00415-005-0922-9","volume":"252","author":"LP Winkel","year":"2005","unstructured":"Winkel LP, Hagemans ML, van Doorn PA, Loonen MC, Hop WJ, Reuser AJ, van der Ploeg AT (2005) The natural course of nonclassic Pompe\u2019s disease: a review of 225 published cases. J Neurol 252:875\u2013884","journal-title":"J Neurol"},{"key":"2258_CR37","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ana.410380316","volume":"38","author":"JH Wokke","year":"1995","unstructured":"Wokke JH, Ausems MG, van den Boogaard MJ, Ippel EF, van Diggelene O, Kroos MA, Boer M, Jennekens FG, Reuser AJ, Ploos van Amstel HK (1995) Genotype-phenotype correlation in adult-onset acid maltase deficiency. Ann Neurol 38:450\u2013454","journal-title":"Ann Neurol"},{"key":"2258_CR38","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/mus.21025","volume":"38","author":"JH Wokke","year":"2008","unstructured":"Wokke JH, Escolar DM, Pestronk A, Jaffe KM, Carter GT, van den Berg LH, Florence J, Mayhew J, Skrinar A, Corzo D, Laforet P (2008) Clinical features of late-onset Pompe disease: a prospective cohort study. Muscle Nerve 38:1236\u20131245","journal-title":"Muscle Nerve"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-013-2258-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-013-2258-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-013-2258-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:31:59Z","timestamp":1559068319000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-013-2258-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,7]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["2258"],"URL":"https:\/\/doi.org\/10.1007\/s00431-013-2258-2","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,7]]}}}